| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/28/2007 | EP1765384A1 Method of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 03/28/2007 | EP1765365A2 Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 03/28/2007 | EP1765354A1 Leptomycin compounds |
| 03/28/2007 | EP1765351A1 Protein kinase inhibitors |
| 03/28/2007 | EP1765344A2 Cancer treatment method |
| 03/28/2007 | EP1765341A2 Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors |
| 03/28/2007 | EP1765336A2 Angiogenesis inhibitors |
| 03/28/2007 | EP1765334A2 Prodrugs of mitotic kinesin inhibitors |
| 03/28/2007 | EP1765328A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 03/28/2007 | EP1765313A2 Compounds for immunopotentiation |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1453532A4 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 03/28/2007 | EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities |
| 03/28/2007 | EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/28/2007 | EP1229933B1 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | CN1938429A Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same |
| 03/28/2007 | CN1938307A 9-substituted 8-oxoadenine compound |
| 03/28/2007 | CN1938282A Imidazol derivatives as tyrosine kinase inhibitors |
| 03/28/2007 | CN1938048A 脂质体制剂 Liposomal formulations |
| 03/28/2007 | CN1938029A Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma |
| 03/28/2007 | CN1938025A Angiogenesis-affecting compounds and methods of use thereof |
| 03/28/2007 | CN1938008A Sustained-release preparations |
| 03/28/2007 | CN1936012A Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use |
| 03/28/2007 | CN1935999A Recombinant human esoderma colyone adenovirus, and its preparing method and use |
| 03/28/2007 | CN1935849A Ultramicro chito polysaccharide product and its processing method |
| 03/28/2007 | CN1935830A Upright datura flower steroid-lactone component, and its preparation and pharmaceutical use for antitumour |
| 03/28/2007 | CN1935812A Metal fullerol and its pharmaceutical use for inhibiting tumour growth |
| 03/28/2007 | CN1935768A Vegeta tive female sex hormone eudesmane compound, and its preparing method and use |
| 03/28/2007 | CN1935277A Preparation for the prophylaxis of restenosis |
| 03/28/2007 | CN1935265A Grafted nano carbon anticancer prodrug, and its preparing method and use |
| 03/28/2007 | CN1935263A Nano carbon suspension injection |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935257A Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
| 03/28/2007 | CN1935245A Nutrient powder with anticancer and cancer proof action |
| 03/28/2007 | CN1935239A Chinese medicine for treating closed damage and pain |
| 03/28/2007 | CN1935228A Chinese medicine composition for preventing and treating breast cancer |
| 03/28/2007 | CN1935224A Chinese medicine for treating malignant tumour |
| 03/28/2007 | CN1935215A Datura flower total steroid, and its preparing method and use |
| 03/28/2007 | CN1935195A Method for extracting female sex hormone from polygonum cuspidatum |
| 03/28/2007 | CN1935160A Method for preparing one-ingredient Chinese medicine julid |
| 03/28/2007 | CN1935156A Remedy |
| 03/28/2007 | CN1935155A Remedy |
| 03/28/2007 | CN1935147A New use of radix sanguisorbae total saponin extract |
| 03/28/2007 | CN1935134A Combination comprising combretastatin and anticancer agents |
| 03/28/2007 | CN1935133A Human leucocyte antigen DR4 subtype protein agonist |
| 03/28/2007 | CN1935129A Pharmaceutical use of paeonol for anti esophageal cancer |
| 03/28/2007 | CN1935128A Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |
| 03/28/2007 | CN1935121A Improved paclitaxel-based antitumor formulation |
| 03/28/2007 | CN1307421C Method and compositions for overcoming resistance to biologic and chemotherapy |
| 03/28/2007 | CN1307311C Carrier pcSH1-n capable of concurrently expressing multiple shRNA and its constructing method |
| 03/28/2007 | CN1307303C Methods and compositions based on VEGF antisense oligonucleotides |
| 03/28/2007 | CN1307200C Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 03/28/2007 | CN1307196C Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307173C Pyrimidineamines as angiogenesis modulators |
| 03/28/2007 | CN1307148C Geranyl compounds |
| 03/28/2007 | CN1307131C Antineoplastic extract of Chinese fan palm and its preparation method and uses |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306947C Method for preparing anti-liver cancer component from selenium-enriched tea leaf and product thereof |
| 03/28/2007 | CN1306929C Ultrapure oral fludara formulation with a fast releasing active substance |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196115 chemotherapeutic treatment is limited to ovarian, colon, breast and oral cancers |
| 03/27/2007 | US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 03/27/2007 | US7196105 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 03/27/2007 | US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant |
| 03/27/2007 | US7196091 Tyrosine kinase inhibitors; controlling signal transduction; antitumor agents; benign prostate hyperplasia; respiratory system disorders |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
| 03/27/2007 | US7196083 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors |
| 03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
| 03/27/2007 | US7196071 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195764 Cancerous disease modifying antibodies |
| 03/27/2007 | US7195750 Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/27/2007 | CA2431660C Stabilised radiopharmaceutical compositions |
| 03/27/2007 | CA2297149C 13-deoxyanthracycline derivatives for treating cancer |
| 03/27/2007 | CA2242750C Antibodies with reduced net positive charge |
| 03/27/2007 | CA2200084C Use of aromatic halides for treating mammalian cell proliferation |
| 03/27/2007 | CA2198727C Cell growth regulator |
| 03/22/2007 | WO2007033232A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | WO2007033196A1 Met kinase inhibitors |
| 03/22/2007 | WO2007033137A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | WO2007032591A1 Composition comprising 1-furan-2-yl-3-pyridin-2-yl-pr0pen0ne having anti-angiogenic activity and cancer growth inhibitory activity |
| 03/22/2007 | WO2007032566A1 Hematopoietic stem cell proliferator |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |